JP2023506707A5 - - Google Patents
Info
- Publication number
- JP2023506707A5 JP2023506707A5 JP2022530281A JP2022530281A JP2023506707A5 JP 2023506707 A5 JP2023506707 A5 JP 2023506707A5 JP 2022530281 A JP2022530281 A JP 2022530281A JP 2022530281 A JP2022530281 A JP 2022530281A JP 2023506707 A5 JP2023506707 A5 JP 2023506707A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cells
- vectors
- irf4
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT115933 | 2019-11-25 | ||
| PT11593319 | 2019-11-25 | ||
| EP20190159.2 | 2020-08-07 | ||
| EP20190159 | 2020-08-07 | ||
| PCT/EP2020/083400 WO2021105234A1 (en) | 2019-11-25 | 2020-11-25 | Compositions for reprogramming cells into dendritic cells type 2 competent for antigen presentation, methods and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023506707A JP2023506707A (ja) | 2023-02-20 |
| JP2023506707A5 true JP2023506707A5 (https=) | 2023-12-04 |
| JP7770028B2 JP7770028B2 (ja) | 2025-11-14 |
Family
ID=73497794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022530281A Active JP7770028B2 (ja) | 2019-11-25 | 2020-11-25 | 細胞を抗原提示に有能な樹状細胞２型に初期化するための組成物、その方法及び使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240139239A1 (https=) |
| EP (1) | EP4065697A1 (https=) |
| JP (1) | JP7770028B2 (https=) |
| KR (1) | KR20220105161A (https=) |
| CN (1) | CN114729320B (https=) |
| CA (1) | CA3156954A1 (https=) |
| IL (1) | IL292894B2 (https=) |
| WO (1) | WO2021105234A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023176806A1 (ja) | 2022-03-18 | 2023-09-21 | 国立研究開発法人産業技術総合研究所 | 線維芽細胞または線維芽細胞様細胞を従来型２型樹状細胞にリプログラミングするための方法 |
| WO2024030930A2 (en) * | 2022-08-01 | 2024-02-08 | The Johns Hopkins University | Compositions and methods for modifying muller glial cells |
| CN120285149A (zh) * | 2024-01-09 | 2025-07-11 | 清华大学 | Pou2f2蛋白或其突变体在预防和治疗感染中的用途 |
| WO2026003071A2 (en) * | 2024-06-25 | 2026-01-02 | Asgard Therapeutics Ab | Novel transcription factor combinations for immune cell reprogramming and related methods |
| CN119708155B (zh) * | 2024-12-30 | 2025-12-09 | 中国药科大学 | 地龙抗血小板寡肽及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4690915A (en) | 1985-08-08 | 1987-09-01 | The United States Of America As Represented By The Department Of Health And Human Services | Adoptive immunotherapy as a treatment modality in humans |
| US5219740A (en) | 1987-02-13 | 1993-06-15 | Fred Hutchinson Cancer Research Center | Retroviral gene transfer into diploid fibroblasts for gene therapy |
| US20040236091A1 (en) * | 2001-03-28 | 2004-11-25 | Chicz Roman M. | Translational profiling |
| US20090215875A1 (en) * | 2008-02-25 | 2009-08-27 | Deneault Eric | Methods and kits for expanding hematopoietic stem cells |
| US8802438B2 (en) | 2010-04-16 | 2014-08-12 | Children's Medical Center Corporation | Compositions, kits, and methods for making induced pluripotent stem cells using synthetic modified RNAs |
| WO2012019168A2 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| AU2012236099A1 (en) | 2011-03-31 | 2013-10-03 | Moderna Therapeutics, Inc. | Delivery and formulation of engineered nucleic acids |
| WO2013070563A1 (en) * | 2011-11-07 | 2013-05-16 | Merck Sharp & Dohme Corp. | Treatment of autoimmune and inflammatory disorders by inhibition of blimp-1 |
| WO2016143826A1 (ja) | 2015-03-09 | 2016-09-15 | 学校法人慶應義塾 | 多能性幹細胞を所望の細胞型へ分化する方法 |
| EP3385373A1 (en) | 2017-04-05 | 2018-10-10 | Centro de Neurociências e Biologia Celular | Compositions for reprogramming cells into dendritic cells or antigen presenting cells, methods and uses thereof |
| WO2018185709A1 (en) | 2017-04-05 | 2018-10-11 | Centro De Neurociencias E Biologia Celular | Compositions for reprogramming cells into dendritic cells or antigen presenting cells, methods and uses thereof |
| KR20220077916A (ko) | 2019-10-10 | 2022-06-09 | 아스가르드 테라퓨틱스 아베 | 세포를 형질세포양 수지상 세포 또는 인터페론 유형 i-생산 세포로 재프로그래밍하기 위한 조성물, 방법 및 이의 용도 |
-
2020
- 2020-11-25 KR KR1020227019462A patent/KR20220105161A/ko active Pending
- 2020-11-25 CA CA3156954A patent/CA3156954A1/en active Pending
- 2020-11-25 EP EP20810982.7A patent/EP4065697A1/en active Pending
- 2020-11-25 JP JP2022530281A patent/JP7770028B2/ja active Active
- 2020-11-25 US US17/778,901 patent/US20240139239A1/en active Pending
- 2020-11-25 CN CN202080078541.XA patent/CN114729320B/zh active Active
- 2020-11-25 WO PCT/EP2020/083400 patent/WO2021105234A1/en not_active Ceased
-
2022
- 2022-05-10 IL IL292894A patent/IL292894B2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023506707A5 (https=) | ||
| RU2361611C2 (ru) | Конструирование рекомбинанта онколитического аденовируса, специфически экспрессирующего иммуномодуляторный фактор gm-csf в опухолевых клетках, и его применение | |
| EP2669381A1 (en) | Method for expression of heterologous proteins using a recombinant negative-strand RNA virus vector comprising a mutated P protein | |
| Yamanaka et al. | Induction of an antitumor immunological response by an intratumoral injection of dendritic cells pulsed with genetically engineered Semliki Forest virus to produce interleukin-18 combined with the systemic administration of interleukin-12 | |
| US12357672B2 (en) | Protein molecule of interleukins 12a and b combined with additional factors | |
| JP2023502318A5 (https=) | ||
| CA2451389A1 (en) | Improved transfection of eukaryotic cells with linear polynucleotides by electroporation | |
| Liu et al. | Transduction and utility of the granulocyte-macrophage colony-stimulating factor gene into monocytes and dendritic cells by adeno-associated virus | |
| CN114729320B (zh) | 用于将细胞重新程序化为能够呈递抗原的树突细胞2型的组合物、方法及其用途 | |
| JP2024522074A5 (https=) | ||
| ES2610781T3 (es) | Amplificación de patógenos independiente de la cepa y vacunas para estos | |
| Wang et al. | Gene gun–mediated oral mucosal transfer of interleukin 12 cDNA coupled with an irradiated melanoma vaccine in a hamster model: Successful treatment of oral melanoma and distant skin lesion | |
| KR100788930B1 (ko) | 항암 조성물 | |
| JP7743980B2 (ja) | ヒトＴ細胞由来ｉＰＳ細胞由来の細胞傷害性Ｔ細胞 | |
| RU2006145306A (ru) | Аденовирусный/альфавитный гибридный вектор для эффективного введения и экспрессии терапевтических генов в опухолевые клетки | |
| Vera et al. | Intratumoral injection of dendritic cells transduced by an SV40-based vector expressing interleukin-15 induces curative immunity mediated by CD8+ T lymphocytes and NK cells | |
| Nemeckova et al. | Experimental therapy of HPV16 induced tumors with IL12 expressed by recombinant vaccinia virus in mice | |
| EP4212618A1 (en) | Method of producing vdelta1+ t cells | |
| JP2024154083A (ja) | ＳＡＲＳ－ＣｏＶ－２特異的細胞傷害性Ｔリンパ球のＴ細胞受容体又はその機能的断片 | |
| CN119265241A (zh) | 一种无相分离转录因子介导启始阶段重编程使细胞年轻化的方法 | |
| JP7810466B2 (ja) | 線維芽細胞または線維芽細胞様細胞を従来型２型樹状細胞にリプログラミングするための方法 | |
| Bontkes et al. | Antigen gene transfer to human plasmacytoid dendritic cells using recombinant adenovirus and vaccinia virus vectors | |
| JP2024516402A5 (https=) | ||
| KR20210012966A (ko) | 불사화된 줄기세포주의 제조 방법 및 이의 용도 | |
| CN114941012B (zh) | 重组间充质干细胞及其应用 |